Loading clinical trials...
Loading clinical trials...
Autologous bone marrow-derived mesenchymal cells will be injected into patients diagnosed with premature ovarian failure
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Jordan
NCT04390308 · Infertility, Female, Premature Ovarian Failure, and more
NCT05462379 · Locally Advanced Cervical Carcinoma, Premature Ovarian Failure
NCT06117982 · Primary Ovarian Insufficiency, Premature Ovarian Failure
NCT04189406 · Turner Syndrome, Infertility, Female, and more
NCT05667428 · Hematopoietic Stem Cell Transplantation, Premature Ovarian Failure
Cell Therapy Center, University of Jordan
Amman
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions